{"disease":{"id":"coagulation-disorder-blood","name":"coagulation disorder blood"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06403163","title":"Transfusion Surveillance in Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT03482128","title":"Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm","phase":"","overall_status":"COMPLETED","enrollment_count":1754,"lead_sponsor_name":"Triemli Hospital","has_results":false},{"nct_id":"NCT04076605","title":"Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":1182,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT05806346","title":"Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":764,"lead_sponsor_name":"Konkuk University Medical Center","has_results":false},{"nct_id":"NCT07164300","title":"Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Ioannina","has_results":false},{"nct_id":"NCT04762550","title":"Thrombin Generation in Liver Transplant Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT03149250","title":"Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Goethe University","has_results":false},{"nct_id":"NCT05591014","title":"The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT04356144","title":"Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections","phase":"","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04159064","title":"Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices","phase":"","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"AHEPA University Hospital","has_results":false},{"nct_id":"NCT01787552","title":"A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04517461","title":"Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04272554","title":"AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Spur Therapeutics","has_results":false},{"nct_id":"NCT04818970","title":"Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Cytokind, Inc.","has_results":false},{"nct_id":"NCT03876301","title":"Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03734588","title":"Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":true}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}